Pharmaceuticals, Biotechnology and Life Sciences
CAMBRIDGE, England & BOSTON, Mass.–(BUSINESS WIRE)–Bicycle Therapeutics, a biotechnology company pioneering a new class of therapeutics based on its proprietary…
MARTINEZ, Calif.–(BUSINESS WIRE)–ExThera Medical Corporation (ExThera) today announced Dr. Stefan Büttner, a senior staff member of the Department of Nephrology,…
FREMONT, Calif.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/STOs?src=hash" target="_blank"gt;#STOslt;/agt;–Verseon is launching a security token offering (STO) aiming to set a new standard for the…
Proceeds will be used to advance clinical development of lead product candidate, KarXT, for additional indications beyond the ongoing Phase…
LONDON–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/STOs?src=hash" target="_blank"gt;#STOslt;/agt;–BlockRules, the blockchain fintech company enforcing complex compliance rules directly on the blockchain, today announces that the…
TOKYO–(BUSINESS WIRE)–Kyowa Kirin Asia Pacific Pte. Ltd. (President: Chikakuni Kotani, Kyowa Kirin Asia Pacific), a wholly owned subsidiary of Kyowa…
REINACH, Switzerland–(BUSINESS WIRE)–Evolva (SIX:EVE) today announced the receipt of a letter from the US Environmental Protection Agency (EPA) shortly ahead of…
Cambridge Based Vaccine Company ImmBio has entered a licensing agreement with the largest vaccine producer in China, CNBG to Co-Develop…
SEATTLE–(BUSINESS WIRE)–Acucela Inc. (“Acucela”), a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), announced…
AUGUSTUS is the largest trial in this high-risk patient population requiring both anticoagulant and antiplatelet therapies PRINCETON, N.J. & NEW…